36 related articles for article (PubMed ID: 24523215)
1. Causes of death and characteristics of decedents with viral hepatitis, United States, 2010.
Ly KN; Xing J; Klevens RM; Jiles RB; Holmberg SD
Clin Infect Dis; 2014 Jan; 58(1):40-9. PubMed ID: 24065331
[TBL] [Abstract][Full Text] [Related]
2. On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial.
Frimpong JA; D'Aunno T; Perlman DC; Strauss SM; Mallow A; Hernandez D; Schackman BR; Feaster DJ; Metsch LR
Trials; 2016 Mar; 17(1):117. PubMed ID: 26936623
[TBL] [Abstract][Full Text] [Related]
3. Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.
Ly KN; Hughes EM; Jiles RB; Holmberg SD
Clin Infect Dis; 2016 May; 62(10):1287-1288. PubMed ID: 26936668
[TBL] [Abstract][Full Text] [Related]
4. Public Health Conditions for Successful Broad-Scale Integration of HIV and HCV Screening in Emergency Departments.
Anderson ES; White DAE
Am J Public Health; 2018 May; 108(5):591-592. PubMed ID: 29617599
[No Abstract] [Full Text] [Related]
5. The Impact of Supportive Housing on Liver-Related Outcomes Among Persons With Hepatitis C Virus Infection.
Miller-Archie SA; Walters SC; Bocour A; Moore MS; Wiewel E; Singh T; Lim S
J Infect Dis; 2022 Oct; 226(Suppl 3):S363-S371. PubMed ID: 36208165
[TBL] [Abstract][Full Text] [Related]
6. Mortality trend due to Hepatitis B and C in the city of São Paulo, 2002-2016.
Sato APS; Koizumi IK; Farias NSO; Silva CRCD; Cardoso MRA; Figueiredo GM
Rev Saude Publica; 2020; 54():124. PubMed ID: 33295592
[TBL] [Abstract][Full Text] [Related]
7. Effect of Hepatocellular Carcinoma on Mortality Among Individuals With Hepatitis B or Hepatitis C Infection in New York City, 2001-2012.
Moore MS; Bocour A; Tran OC; Qiao B; Schymura MJ; Laraque F; Winters A
Open Forum Infect Dis; 2018 Jul; 5(7):ofy144. PubMed ID: 30019001
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C coinfection adversely affects the life expectancy of people living with HIV in northwestern Poland.
Leszczyszyn-Pynka M; Ciejak P; Maciejewska K; Witak-Jędra M; Karasińska-Cieślak M; Karpińska E; Wawrzynowicz-Syczewska M; Parczewski M
Arch Med Sci; 2018 Apr; 14(3):554-559. PubMed ID: 29765442
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus testing for case identification in persons born during 1945-1965: Results from three randomized controlled trials.
Yartel AK; Rein DB; Brown KA; Krauskopf K; Massoud OI; Jordan C; Kil N; Federman AD; Nerenz DR; Brady JE; Kruger DL; Smith BD
Hepatology; 2018 Feb; 67(2):524-533. PubMed ID: 28941361
[TBL] [Abstract][Full Text] [Related]
10. Neighborhood Inequalities in Hepatitis C Mortality: Spatial and Temporal Patterns and Associated Factors.
Ford MM; Desai PS; Maduro G; Laraque F
J Urban Health; 2017 Oct; 94(5):746-755. PubMed ID: 28623451
[TBL] [Abstract][Full Text] [Related]
11. Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals.
Oliver NT; Hartman CM; Kramer JR; Chiao EY
AIDS; 2016 Oct; 30(16):2469-2476. PubMed ID: 27753678
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011.
Pinchoff J; Tran OC; Chen L; Bornschlegel K; Drobnik A; Kersanske L; Fuld J
Epidemiol Infect; 2016 Dec; 144(16):3354-3364. PubMed ID: 27510414
[TBL] [Abstract][Full Text] [Related]
13. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.
Omata M; Kanda T; Wei L; Yu ML; Chuang WL; Ibrahim A; Lesmana CR; Sollano J; Kumar M; Jindal A; Sharma BC; Hamid SS; Dokmeci AK; Al-Mahtab M; McCaughan GW; Wasim J; Crawford DH; Kao JH; Yokosuka O; Lau GK; Sarin SK
Hepatol Int; 2016 Sep; 10(5):681-701. PubMed ID: 27229718
[TBL] [Abstract][Full Text] [Related]
14. Modelling the prevalence of hepatitis C virus amongst blood donors in Libya: An investigation of providing a preventive strategy.
Daw MA; Shabash A; El-Bouzedi A; Dau AA; Habas M;
World J Virol; 2016 Feb; 5(1):14-22. PubMed ID: 26870670
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus Disease Progression in People Who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis.
Combellick J; Smith DJ; Jordan AE; Hagan H
JMIR Res Protoc; 2015 Jun; 4(2):e68. PubMed ID: 26054636
[TBL] [Abstract][Full Text] [Related]
16. Deaths among people with hepatitis C in New York City, 2000-2011.
Pinchoff J; Drobnik A; Bornschlegel K; Braunstein S; Chan C; Varma JK; Fuld J
Clin Infect Dis; 2014 Apr; 58(8):1047-54. PubMed ID: 24523215
[TBL] [Abstract][Full Text] [Related]
17. Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis C.
Mahure SA; Bosco JA; Slover JD; Vigdorchik J; Iorio R; Schwarzkopf R
Clin Orthop Relat Res; 2018 Feb; 476(2):356-369. PubMed ID: 29529669
[TBL] [Abstract][Full Text] [Related]
18. Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.
Smit C; van den Berg C; Geskus R; Berkhout B; Coutinho R; Prins M
J Acquir Immune Defic Syndr; 2008 Feb; 47(2):221-5. PubMed ID: 18223361
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
